Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

IsraelRecruitingPHASE2, PHASE3

Conditions

Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

VA Greater LA Healthcare System, Los Angeles, California, United States
Contact: Study coordinator (Janake Wijesuriya) · janake.wijesuriya@va.gov
Contact: Principal Investigator (Gholam Reza Berenji)
VA Palo Alto Health Care System, Palo Alto, California, United States
Contact: Study coordinator (Niko Del Mar) · niko.delmar@va.gov · 650-493-5000
Contact: Principal Investigator (Minal Vasanawala)
Stanford University Medical Center, Palo Alto, California, United States
Contact: Study coordinator (Mikayla Easterling) · maeast@stanford.edu
Contact: Principal Investigator (Hong Song)
Sansum Clinic, Santa Barbara, California, United States
Contact: Study coordinator (Jessica Wong) · jessica.wong2@sutterhealth.org · 805-563-5800
Contact: Principal Investigator (Gregg Newman)
Saint Johns Cancer Institute, Santa Monica, California, United States
Contact: Study coordinator (Joey Dumadag) · joey.dumadag@providence.org · 310-829-8569
Contact: Principal Investigator (Przemyslaw Twardowski)
Hartford Hospital, Hartford, Connecticut, United States
Contact: Study coordinator (Melanie Manning) · Melanie.Manning@hhchealth.org
Contact: Principal Investigator (Andrew Salner)
AdventHealth, Orlando, Florida, United States
Contact: Study coordinator (Joseph Guzzo) · joseph.guzzo@adventhealth.com · 407-303-3235
Contact: Principal Investigator (Ravi Shridhar)
University Cancer and Blood Center LLC, Athens, Georgia, United States
Contact: Study coordinator (Christen Nicole Cooper Pope) · npope@universitycancer.com · +1 706 353 2990
Contact: Principal Investigator (Petros Nikolinakos)
Emory University, Atlanta, Georgia, United States
Contact: Study coordinator (Jalpa Patel) · jalpa.r.patel@emory.edu · +1 404 778 1835
Contact: Principal Investigator (Shahid Sattar Ahmed.)
Indiana University, Indianapolis, Indiana, United States
Contact: Study coordinator (Marie Burton) · mariburt@iu.edu
Contact: Principal Investigator (Nabil Adra)
University of Kansas Hospital, Kansas City, Kansas, United States
Contact: Study coordinator (Kelsey Schwensen) · kschwensen@kumc.edu
Contact: Principal Investigator (Xinglei Shen)
East Jefferson Hospital, Metairie, Louisiana, United States
Contact: Study coordinator (Alexandra Lieberman) · alexandra.lieberman@lcmchealth.org
Contact: Principal Investigator (Alton Oliver Sartor)
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Michael Bonhomme) · michael_bonhomme@dfci.harvard.edu · 617-632-5136
Contact: Principal Investigator (Xiao Wei.)
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Study coordinator (Ooviya Sathiyamoorthy) · osathiya@bidmc.harvard.edu · 617-643-9923
Contact: Principal Investigator (David J Einstein)
WA Uni School Of Med, St Louis, Missouri, United States
Contact: Study coordinator (Collin Welch) · c.welch@wustl.edu · 314-454-8293
Contact: Principal Investigator (Jeff Michalski)
Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Study coordinator (Marlene Bridwell) · mbridwell@nebraskacancer.com · 402-334-4773
Contact: Principal Investigator (Samuel Mehr)
New Jersey Urology LLC, Voorhees Township, New Jersey, United States
Contact: Study coordinator (Gabriela Mercado) · gmercado3@nj-urology.com · 856-673-1613
Contact: Principal Investigator (Gordon Brown)
Associated Med Professionals of NY, Syracuse, New York, United States
Contact: Study coordinator (Nathan Forrest) · nathan.forrest@ampofny.com
Contact: Principal Investigator (Steven Finkelstein)
Montefiore Medical Center, The Bronx, New York, United States
Contact: Study coordinator (Tahrima Chowdhury) · tahchowdhu@montefiore.org · 718-920-6642
Contact: Principal Investigator (Benjamin A Gartrell)
Central Ohio Urology Group, Gahanna, Ohio, United States
Contact: Study coordinator (Sarah Faisal) · sarah.faisal@us-uro.com
Contact: Principal Investigator (Benjamin Martin)
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Candice Schewbel) · candice.schwebel@fccc.edu · 215-728-3075
Contact: Principal Investigator (Matthew Zibelman)
Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
Contact: Study coordinator (Rebecca Floyd) · rebecca.floyd@startresearch.com · 843-839-1679
Contact: Principal Investigator (Neal D Shore)
Texas Oncology, Dallas, Texas, United States
Contact: Study coordinator (Marian Heaven) · marian.heaven@usoncology.com · 512-427-9467
Contact: Principal Investigator (Michael P Herman)
Urology San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Sandra Davila) · sandra.davila@usa-clinicaltrials.com
Contact: Principal Investigator (Daniel Saltzstein)
Utah Intermountain Medical Center, Murray, Utah, United States
Contact: Study coordinator (Becky Arroyo) · becky.arroyo@imail.org
Contact: Principal Investigator (David Gill)
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Contact: Study coordinator (Brianna Woo) · bwoo@fredhutch.org
Contact: Principal Investigator (Ruben Raychaudhuri)
Medical College Of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Nadia Thomas) · nathomas@mcw.edu
Contact: Principal Investigator (Deepak Kilari)
Novartis Investigative Site, Darlinghurst, New South Wales, Australia
Novartis Investigative Site, Herston, Queensland, Australia
Novartis Investigative Site, Melbourne, Victoria, Australia
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, Fuzhou, Fujian, China
Novartis Investigative Site, Wuhan, Hubei, China
Novartis Investigative Site, Wuhan, Hubei, China
Novartis Investigative Site, Nanjing, Jiangsu, China
Novartis Investigative Site, Nanjing, Jiangsu, China
Novartis Investigative Site, Shenyang, Liaoning, China
Novartis Investigative Site, Xian, Shanxi, China
Novartis Investigative Site, Xian, Shanxi, China
Novartis Investigative Site, Chengdu, Sichuan, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Guangzhou, China
Novartis Investigative Site, Shanghai, China
Novartis Investigative Site, Shanghai, China
Novartis Investigative Site, Tianjin, China
Novartis Investigative Site, Hong Kong, Hong Kong
Novartis Investigative Site, Beersheba, Israel
Novartis Investigative Site, Haifa, Israel
Novartis Investigative Site, Jerusalem, Israel
Novartis Investigative Site, Petah Tikva, Israel
Novartis Investigative Site, Ramat Gan, Israel
Novartis Investigative Site, Tel Aviv, Israel
Novartis Investigative Site, Kashiwa, Chiba, Japan
Novartis Investigative Site, Sapporo, Hokkaido, Japan
Novartis Investigative Site, Kobe, Hyōgo, Japan
Novartis Investigative Site, Yokohama, Kanagawa, Japan
Novartis Investigative Site, Chiba, Japan
Novartis Investigative Site, Fukuoka, Japan
Novartis Investigative Site, Fukuoka, Japan
Novartis Investigative Site, Fukuoka, Japan
Novartis Investigative Site, Fukushima, Japan
Novartis Investigative Site, Ishikawa, Japan
Novartis Investigative Site, Kyoto, Japan
Novartis Investigative Site, Petaling Jaya, Selangor, Malaysia
Novartis Investigative Site, Petaling Jaya, Selangor, Malaysia
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Basel, Switzerland
Novartis Investigative Site, Bellinzona, Switzerland
Novartis Investigative Site, Bern, Switzerland
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Taoyuan, Taiwan

View source on ClinicalTrials.gov Contact study team (email)